Spots Global Cancer Trial Database for phase ii trial
Every month we try and update this database with for phase ii trial cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II | NCT04480372 | Malignant Pleur... Non-small Cell ... | Gemcitabine Atezolizumab | 18 Years - | Swiss Group for Clinical Cancer Research | |
| ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. | NCT02933801 | Prostate Cancer... Prostate Cancer | ODM-201 Placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer | NCT02404506 | Breast Cancer Adenocarcinoma | Eribulin mesila... | 70 Years - | Swiss Group for Clinical Cancer Research | |
| ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. | NCT02933801 | Prostate Cancer... Prostate Cancer | ODM-201 Placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer. | NCT04212026 | Metastatic Panc... | Nivolumab | 18 Years - | University Hospital, Basel, Switzerland | |
| SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy | NCT02945813 | Prostate Cancer | Metformin Salvage Radioth... | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
| ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. | NCT02933801 | Prostate Cancer... Prostate Cancer | ODM-201 Placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| PET With [18F]HX4 in Head and Neck Cancer | NCT01347281 | Cancer of the H... | Injection of [1... | 18 Years - 100 Years | Maastricht Radiation Oncology | |
| Tumor Hypoxia With HX4 PET in Several Diseases | NCT02584400 | Prostatic Neopl... Esophageal Neop... Neoplasm Metast... Rectal Neoplasm... Brain Neoplasm,... | Injection with ... | 18 Years - | Maastricht Radiation Oncology | |
| Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment | NCT01015534 | Brain Neoplasms | Temozolomide Whole brain irr... | 18 Years - 80 Years | Instituto Nacional de Cancerologia de Mexico | |
| Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) | NCT06401980 | Metastatic Cast... | Darolutamide Standard of car... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Cetuximab for Elderly Patients With mCRC | NCT01718808 | Metastatic Colo... | Cetuximab Capecitabine | 70 Years - | Swiss Group for Clinical Cancer Research | |
| Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | NCT04472949 | Small Cell Lung... Lung Cancer | Durvalumab carboplatin etoposide Thoracic radiot... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer | NCT01020864 | Head and Neck N... | Cetuximab Carboplatin Vinorelbine | 18 Years - 80 Years | Odense University Hospital | |
| Study of Arsenic Trioxide in Small Cell Lung Cancer | NCT01470248 | Lung Cancer Cancer of Lung Pulmonary Cance... Pulmonary Neopl... Carcinoma, Smal... | Arsenic Trioxid... | 18 Years - | Emory University | |
| A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | NCT00001839 | Hematologic Dis... Myelodysplastic... | Antithymocyte g... Cyclosporine | - | National Institutes of Health Clinical Center (CC) | |
| A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | NCT00001839 | Hematologic Dis... Myelodysplastic... | Antithymocyte g... Cyclosporine | - | National Institutes of Health Clinical Center (CC) | |
| Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. | NCT03213301 | Malignant Pleur... | Lurbinectedin | 18 Years - | Swiss Group for Clinical Cancer Research | |
| A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | NCT00001839 | Hematologic Dis... Myelodysplastic... | Antithymocyte g... Cyclosporine | - | National Institutes of Health Clinical Center (CC) | |
| Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | NCT04472949 | Small Cell Lung... Lung Cancer | Durvalumab carboplatin etoposide Thoracic radiot... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| PET With [18F]HX4 in Head and Neck Cancer | NCT01347281 | Cancer of the H... | Injection of [1... | 18 Years - 100 Years | Maastricht Radiation Oncology | |
| Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment | NCT01015534 | Brain Neoplasms | Temozolomide Whole brain irr... | 18 Years - 80 Years | Instituto Nacional de Cancerologia de Mexico | |
| Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. | NCT03213301 | Malignant Pleur... | Lurbinectedin | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. | NCT03213301 | Malignant Pleur... | Lurbinectedin | 18 Years - | Swiss Group for Clinical Cancer Research | |
| A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation | NCT04308837 | Gastric Cancer Stomach Cancer | Paclitaxel Carboplatin Dexamethasone Diphenhydramine Famotidine Palonosetron 3D conformal or... Surgical resect... Adjuvant Chemot... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer | NCT02404506 | Breast Cancer Adenocarcinoma | Eribulin mesila... | 70 Years - | Swiss Group for Clinical Cancer Research |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
